New from NPG

Nature Insight Molecular cancer diagnostics

This Insight highlights key approaches for the discovery and validation of cancer biomarkers, at the level of DNA, RNA and protein analysis. It also focuses on non-invasive imaging tools and serum analyses that will be important in detecting tumours and monitoring the course of cancer therapy.

Access the Insight free online for six months here

Produced with support from Nestle

naturejobs

More science jobs
Post a job for free

natureproducts

NPG Journals in cancer Featured Articles
British Journal of Cancer Analysis of c-KIT expression and KIT gene mutation in human mucosal melanomas
British Journal of Cancer Breast cancer risks in women with a family history of breast or ovarian cancer who have tested negative for a BRCA1 or BRCA2 mutation
British Journal of Cancer Rates of inclusion of teenagers and young adults in England into National Cancer Research Network clinical trials: Report from the National Cancer Research Institute (NCRI) Teenage and Young Adult Clinical Studies Development Group
Cancer Gene Therapy An oncolytic adenovirus expressing granulocyte macrophage colony-stimulating factor shows improved specificity and efficacy for treating human solid tumors FREE
Cell Death & Differentiation Control of autophagy by oncogenes and tumor suppressor genes FREE
EMBO Reports DNA-PK suppresses a p53-independent apoptotic response to DNA damage.
European Journal of Human Genetics Breast cancer susceptibility genes analysed into three groups: Genomics and breast cancer: the different levels of inherited susceptibility FREE
European Journal of Human Genetics Breast cancer susceptibility: current knowledge and implications for genetic counselling
Molecular Systems Biology Analysis of pairwise cell interactions using an integrated dielectrophoretic-microfluidic system FREE
EMBO Journal Cancer induction by restriction of oncogene expression to the stem cell compartment FREE
Nature Reviews Cancer Targeting cancer with small molecule kinase inhibitors
Nature Clinical Practice Oncology Capecitabine: have we got the dose right? FREE

ADVERTISEMENT